CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to HSCSW

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
HSCSWPhase 2

Valsartan 40 mg Phase 2 Est. Readout

Valsartan 40 mg
Q3 2027~Q
CT.gov
00%
Competitive Landscape

1 competitor in Pulmonary Arterial Hypertension

View Full Landscape
Drug Information

Target Indication

Pulmonary Arterial Hypertension

Clinical Trial

NCT06053580

Last updated: 9/12/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.